{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:04:38Z","timestamp":1794002678460,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tmreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.tmrv.2016.11.002","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T03:31:10Z","timestamp":1479353470000},"page":"149-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Role of the Laboratory and Transfusion Service in the Management of Ebola Virus Disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Scott A.","family":"Koepsell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Roback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2016.11.002_bb0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-1702(95)00080-1","article-title":"Differentiation of filoviruses by electron microscopy","volume":"39","author":"Geisbert","year":"1995","journal-title":"Virus Res"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0010","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-010-0814-x","article-title":"Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations","volume":"155","author":"Kuhn","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0015","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.1259657","article-title":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak","volume":"345","author":"Gire","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1469-0691.2011.03535.x","article-title":"Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa","volume":"17","author":"Leroy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15252\/emmm.201404792","article-title":"Investigating the zoonotic origin of the West African Ebola epidemic","volume":"7","author":"Mari Saez","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ije\/dyv307","article-title":"Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis","volume":"45","author":"Brainard","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000149300","article-title":"Filoviridae: a taxonomic home for Marburg and Ebola viruses?","volume":"18","author":"Kiley","year":"1982","journal-title":"Intervirology"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.4RI0316-099RR","article-title":"Molecular mechanisms of Ebola pathogenesis","author":"Rivera","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13054-016-1325-2","article-title":"Ebola virus disease and critical illness","volume":"20","author":"Leligdowicz","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJMoa1504874","article-title":"Clinical management of Ebola virus disease in the United States and Europe","volume":"374","author":"Uyeki","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathol-020712-164041","article-title":"Pathogenesis of the viral hemorrhagic fevers","volume":"8","author":"Paessler","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0060","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ajic.2016.04.216","article-title":"Epidemiologic characteristics, clinical manifestations, and risk factors of 139 patients with Ebola virus disease in western Sierra Leone","volume":"44","author":"Xu","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/1117-1936.186299","article-title":"The West African Ebola virus disease epidemic 2014-2015: a commissioned review","volume":"23","author":"Omilabu","year":"2016","journal-title":"Niger Postgrad Med J"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1056\/NEJMc1510305","article-title":"Ebola virus disease among male and female persons in West Africa","volume":"374","author":"W.E.R. Team","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0075","author":"C.f.D.C.a. Prevention"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jama.1997.03550050061035","article-title":"Clinical recognition and management of patients exposed to biological warfare agents","volume":"278","author":"Franz","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0085","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1309\/LMTULFM62W3RKMYI","article-title":"An integrated approach to laboratory testing for patients with Ebola virus disease","volume":"45","author":"Iwen","year":"2014","journal-title":"Lab Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0090","first-page":"1531","article-title":"The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol","volume":"109","author":"Piercy","year":"2010","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0095","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1309\/LMTMW3VVN20HIFS","article-title":"Laboratory test support for Ebola patients within a high-containment facility","volume":"45","author":"Hill","year":"2014","journal-title":"Lab Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0100","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1111\/trf.12913","article-title":"Ebola virus disease, transmission risk to laboratory personnel, and pretransfusion testing","volume":"54","author":"Katz","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOH.0000000000000191","article-title":"The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease","volume":"22","author":"Winkler","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0110","first-page":"271","volume":"56","year":"1978","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.2.6086.541","article-title":"A case of Ebola virus infection","volume":"2","author":"Emond","year":"1977","journal-title":"Br Med J"},{"issue":"Suppl. 1","key":"10.1016\/j.tmrv.2016.11.002_bb0120","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1086\/514298","article-title":"Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee","volume":"179","author":"Mupapa","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.tmrv.2016.11.002_bb0125","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1086\/520587","article-title":"Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates","volume":"196","author":"Jahrling","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0130","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.73.7.6024-6030.1999","article-title":"Ebola virus can be effectively neutralized by antibody produced in natural human infection","volume":"73","author":"Maruyama","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0135","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1128\/JVI.75.10.4649-4654.2001","article-title":"Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication","volume":"75","author":"Gupta","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0140","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0145","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMoa1409838","article-title":"Clinical care of two patients with Ebola virus disease in the United States","volume":"371","author":"Lyon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0150","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cid\/civ334","article-title":"The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States","volume":"61","author":"Kraft","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.tmrv.2016.11.002_bb0155","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/trf.13393","article-title":"Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro","volume":"56","author":"Cap","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/civ395","article-title":"Administration of brincidofovir and convalescent plasma in a patient with Ebola virus disease","volume":"61","author":"Florescu","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M15-0530","article-title":"Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States","volume":"163","author":"Liddell","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.socscimed.2015.11.017","article-title":"Taking the bull by the horns: ethical considerations in the design and implementation of an Ebola virus therapy trial","volume":"148","author":"Kombe","year":"2016","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0175","first-page":"1208","article-title":"Large-scale convalescent blood and plasma transfusion therapy for Ebola virus disease","volume":"211","author":"Colebunders","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cid\/civ680","article-title":"The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field","volume":"62","author":"van Griensven","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0185","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S2213-2600(15)00180-0","article-title":"Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain","volume":"3","author":"Mora-Rillo","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for Ebola virus disease in Guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2016.11.002_bb0195","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316301390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316301390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T10:09:14Z","timestamp":1601201354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796316301390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0887796316301390"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.11.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of the Laboratory and Transfusion Service in the Management of Ebola Virus Disease","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}